Keep your opinions sharp and informed with a helpful summary of The Globe’s most provocative columns, covering politics, ...

Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.

Donald Trump has insisted the US does not need a plan B as it has already hit Iran ‘very hard’ (Picture: Getty) Donald Trump ...